LIVER CANCER - FDA approved drugs & results from clinical trials

This report is specific for Liver Cancer. 
This 13 page report has 9 sections, which includes basic explanation of the disease state, 5-year survival rate, basic outline of current therapeutic approaches, information on 7 FDA approved drugs for hepatocellular carcinoma (liver cancer), outline of the mechanism of action for each drug, outcome of clinical trials measured as response rate, median overall survival and disease progression-free survival, ongoing clinical trials, information on support groups and list of other credible resources to support your own research.